Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. [electronic resource]
Producer: 20070130Description: 1640-8 p. digitalISSN:- 1527-6465
- Adult
- Cholesterol -- blood
- Cholesterol, LDL -- blood
- Creatinine -- blood
- Cyclosporine -- therapeutic use
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Everolimus
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Immunosuppressive Agents -- administration & dosage
- Incidence
- Kidney -- physiopathology
- Leukopenia -- chemically induced
- Liver Transplantation
- Longitudinal Studies
- Male
- Middle Aged
- Prednisone -- therapeutic use
- Sirolimus -- administration & dosage
- Thrombocytopenia -- chemically induced
- Treatment Outcome
- Triglycerides -- blood
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.